CNTX
Price
$1.90
Change
-$0.08 (-4.04%)
Updated
Oct 4, 02:51 PM (EDT)
34 days until earnings call
TYRA
Price
$22.11
Change
+$0.53 (+2.46%)
Updated
Oct 4, 10:36 AM (EDT)
27 days until earnings call
Ad is loading...

CNTX vs TYRA

Header iconCNTX vs TYRA Comparison
Open Charts CNTX vs TYRABanner chart's image
Context Therapeutics
Price$1.90
Change-$0.08 (-4.04%)
Volume$1.5K
CapitalizationN/A
Tyra Biosciences
Price$22.11
Change+$0.53 (+2.46%)
Volume$157
CapitalizationN/A
View a ticker or compare two or three
CNTX vs TYRA Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CNTX vs. TYRA commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a StrongBuy and TYRA is a StrongBuy.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (CNTX: $1.98 vs. TYRA: $21.58)
Brand notoriety: CNTX and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 282% vs. TYRA: 85%
Market capitalization -- CNTX: $147.37M vs. TYRA: $1.23B
CNTX [@Biotechnology] is valued at $147.37M. TYRA’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while TYRA’s TA Score has 2 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 5 bearish.
  • TYRA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than TYRA.

Price Growth

CNTX (@Biotechnology) experienced а +7.03% price change this week, while TYRA (@Biotechnology) price change was -7.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.22%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was -6.35%.

Reported Earning Dates

CNTX is expected to report earnings on Nov 07, 2024.

TYRA is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+3.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TYRA($1.23B) has a higher market cap than CNTX($147M). CNTX YTD gains are higher at: 75.221 vs. TYRA (55.812). CNTX has higher annual earnings (EBITDA): -20.01M vs. TYRA (-95.02M). TYRA has more cash in the bank: 374M vs. CNTX (102M). CNTX (0) and TYRA (0) have equivalent revenues.
CNTXTYRACNTX / TYRA
Capitalization147M1.23B12%
EBITDA-20.01M-95.02M21%
Gain YTD75.22155.812135%
P/E RatioN/AN/A-
Revenue00-
Total Cash102M374M27%
Total DebtN/A6.4M-
TECHNICAL ANALYSIS
Technical Analysis
CNTXTYRA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TFOIX31.16N/A
N/A
Transamerica Capital Growth I
GQLVX14.29-0.02
-0.14%
Glenmede Quant US Large Cap Value Equity
CAABX26.04-0.08
-0.31%
ClearBridge Sustainability Leaders C
JSERX59.38-0.24
-0.40%
JPMorgan Small Cap Equity R5
MNVRX30.87-0.16
-0.52%
Madison Investors R6

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+4.76%
FATE - CNTX
30%
Poorly correlated
-2.80%
DSGN - CNTX
29%
Poorly correlated
-5.03%
CMMB - CNTX
29%
Poorly correlated
N/A
HRMY - CNTX
27%
Poorly correlated
-2.25%
TYRA - CNTX
25%
Poorly correlated
-3.57%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with PRME. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-3.57%
PRME - TYRA
42%
Loosely correlated
-0.58%
ALLO - TYRA
41%
Loosely correlated
+3.16%
NTLA - TYRA
39%
Loosely correlated
-4.85%
RCKT - TYRA
38%
Loosely correlated
-5.31%
ORMP - TYRA
38%
Loosely correlated
+0.84%
More